New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out
Loading...
Shape
AstraZeneca PLC
AZNCF
Shape
US Flag

PNK

238B

Drug Manufacturers - General

Next Earning date - 29 Apr 2025

238B

Drug Manufacturers - General

Next Earning date - 29 Apr 2025

153.56USD

0.00 ( 0.00%)
Market Open
favorite-chart

Relative Strenght

favorite-chart

Volume Buzz

-92%
favorite-chart

Earning Acce

No
favorite-chart

Dist 52w H.

12%

Quote Panel

Shape
Updated March 17, 2025
1W -0.43 % 1M 5.34 % 3M 20.28 % 1Y 19.79 %

Key Metrics

Shape
  • Market Cap

    238.11B


  • Shares Outstanding

    1.55B


  • Share in Float

    1.47B


  • Dividende

    3.11306


  • Earning Date

    29 Apr 2025


  • Price Target

    153.56


  • Average Volume

    2482


  • Beta

    0.157


  • Range

    120.64-175


  • Industry

    Drug Manufacturers - General


  • Website

    https://www.astrazeneca.com


  • Sector

    Healthcare


Fundamentals

Shape

34.01x

P/E Ratio

4.45x

P/S Ratio

5.91x

P/B Ratio

0.7

Debt/Equity

13.0%

Net Margin

$4.5

EPS

How AZNCF compares to sector?

P/E Ratio

Relative Strength

Shape

AZNCF

Sector

loading...

Top 5 RS in Group

Symbol

Company

RS

5-Day Perf.

Forecast

Shape

$57B

Shape286%

2025-Revenue

$8.96

Shape824%

2025-EPS

$15B

Shape228%

2025-EBITDA

Analyst rating

Strong Sell

Sell

Buy

Neutral

Strong Buy

Shape

Price Target

NaN(-100.00%)

Number of analyst

Last analyst upgrade/downgrade

No Data Available

Earnings GrowthShape

status-upYoY

Current

Estimates

Q1.23

arrow
arrow

-39%

1.16
vs 1.89

Q2.23

arrow
arrow

-32%

1.17
vs 1.72

Q3.23

arrow
arrow

-47%

0.88
vs 1.67

Q4.23

arrow
arrow

-55%

0.61
vs 1.38

Q1.24

arrow
arrow

+21%

1.4
vs 1.16

Q2.24

arrow
arrow

+6%

1.24
vs 1.17

Q3.24

arrow
arrow

+4%

0.92
vs 0.88

Q4.24

arrow
arrow

+56%

0.96
vs 0.61

Q1.25

arrow
arrow

+58%

2.22
vs 1.4

Q2.25

arrow
arrow

+75%

2.17
vs 1.24

Sales GrowthShape

status-upYoY

Current

Estimates

Q1.23

arrow
arrow

-4%

10.9B  vs 11.4B

Q2.23

arrow
arrow

+6%

11.4B  vs 10.8B

Q3.23

arrow
arrow

+5%

11.5B  vs 11B

Q4.23

arrow
arrow

+10%

12.3B  vs 11.2B

Q1.24

arrow
arrow

+16%

12.6B  vs 10.9B

Q2.24

arrow
arrow

+14%

13B  vs 11.4B

Q3.24

arrow
arrow

+18%

13.6B  vs 11.5B

Q4.24

arrow
arrow

+21%

14.9B  vs 12.3B

Q1.25

arrow
arrow

+9%

13.7B  vs 12.6B

Q2.25

arrow
arrow

+8%

13.9B  vs 13B

Return on EquityShape

status-upQoQ

Q1.23

arrow
arrow

+5%

0.05
vs 0.02

Q2.23

arrow
arrow

+5%

0.05
vs 0.05

Q3.23

arrow
arrow

+4%

0.04
vs 0.05

Q4.23

arrow
arrow

+2%

0.02
vs 0.04

Q1.24

arrow
arrow

+6%

0.06
vs 0.02

Q2.24

arrow
arrow

+5%

0.05
vs 0.06

Q3.24

arrow
arrow

+4%

0.04
vs 0.05

Q4.24

arrow
arrow

+4%

0.04
vs 0.04

Institutionnal OwnershipShape

status-up

Earnings Growth

Latest News